Projects per year
Projects
Search results
-
Active
A randomised controlled trial of Focal Electrically Administered Seizure Therapy (FEAST) in patients with severe depression
Loo, C., Martin, D., Fitzgerald, P., Dokos, S., Hadzi-Pavlovic, D., George, M., Bai, S. & Boonstra, T.
1/01/19 → 31/12/23
Project: Research
-
A statistical framework to exploit routine pathogen genomics data for public health
Holt, K. & Duchene, S.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
-
The role of NOX4 in antioxidant defence and mitochondrial biogenesis in muscle
Tiganis, T., McLean, C., Bennett, A. M., Lee-Young, R., Mitchell, C. & Hawley, J.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
-
Halting the atopic march: harnessing the skin microbiome in early life to prevent allergies
1/01/19 → 31/12/21
Project: Research
-
Harnessing the microbiome to protect against chronic lung diseases
1/01/19 → 31/12/23
Project: Research
-
Molecular control of postnatal heart development
Porrello, E. R., El-Osta, S., Delbridge, L. M. & Hudson, J.
1/01/19 → 31/12/21
Project: Research
-
Simultaneously targeting airway contraction and fibrosis as a new therapeutic strategy for asthma
Bourke, J., Royce, S., Bardin, P., Westall, G., Grainge, C., Oliver, B. G., Samuel, C. & Wadsworth, S.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
-
Improving the safety and predictable efficacy of thrombolytic therapy in acute ischaemic stroke
Medcalf, R., Boyd, B. & Cloud, G.
1/01/19 → 31/12/22
Project: Research
-
Effect of clonal haematopoiesis and aspirin on outcomes in elderly: the ASPREE-HAEM study
McQuilten, Z., Curtis, D., Wood, E., Wolfe, R., Lacaze, P., Sebra, R., Murphy, A. J., Riaz, M., McNeil, J., Woods, R. & Wong, N.
National Health and Medical Research Council (NHMRC) (Australia)
1/01/19 → 31/12/21
Project: Research
-
MSPP: Multiple Sclerosis: Pregnancy and Prognosis
Jokubaitis, V., Van Der Walt, A., Hellwig, K., McCombe, P. & Stankovich, J.
1/01/19 → 31/12/22
Project: Research
-
A phase 3, open-label, randomised study to compare the efficacy and safety of luspatercept (Ace-536) versus epoetin alfa for the treatment of anaemia due to Ipss-R very low, low or intermediate risk myelodysplastic syndromes (MDS) in ESA naive subjects who require red blood cell transfusions [ACE-536-MDS-002]
Kenealy, M. & Baker, E.
20/12/18 → 31/12/24
Project: Research
-
ICAN: Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma – the ICAN study
McQuilten, Z., Wood, E., Opat, S., Mulligan, S., Slavin, M., Crispin, P., Morrissey, O., Zalcberg, J., Teh, B. W., Waters, N., Rowsell, L., Crassini, K. & Wong, J.
19/12/18 → 31/12/21
Project: Research
-
Next Generation of bespoke treatments: Artificial intelligence aiding in prognoses in treatment plans
Law, M. & Seah, J.
18/12/18 → 31/12/21
Project: Research
-
MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.
17/12/18 → 30/11/22
Project: Research
-
A phase 1a/1b study of FPT155 in patients with advanced solid tumours [FPT155-001].
Richardson, G. & Baker, E.
10/12/18 → 31/12/23
Project: Research
-
A phase 1b/2 study of BMS-813160 in combination with chemotherapy or Nivolumab in patients with advanced solid tumors [CV202-103].
Richardson, G. & Baker, E.
10/12/18 → 31/12/24
Project: Research
-
Long-term, prospective, multinational, parallel-cohort study monitoring safety in patients with MS newly started on fingolimod once daily or treated with another disease-modifying therapy.
Van Der Walt, A. & Germaine, J.
30/11/18 → 31/01/24
Project: Research
-
Adjuvant Therapy with Pembrolizumab versus Placebo in Resected High-risk Stage II Melanoma: A Randomized, Double-blind Phase 3 Study.
Haydon, A. & Cross, N.
21/11/18 → 31/12/23
Project: Research
-
A Phase III, Randomized, Double-blind, Placebo-Controlled, Multicenter study to Evaluate the Efficacy and Safety of Baloxavir Marboxil in Combination with Standard of Care Neuraminidase Inhibitor in Hospitalized Patients with Severe Influenza.
Cheng, A. & Roney, J.
15/11/18 → 15/05/21
Project: Research
-
Biomarkers of Brain Concussion
Shultz, S., O'Brien, T., Kosofsky, B., Germaine, J., Smith, R., Fielding, J., Clough, M. & Wright, D.
14/11/18 → 30/06/22
Project: Research
-
CBTCT: NHMRC Centre of Research Excellence: Centre for Blood Transplant and Cell Therapy (CBTCT)
Gottlieb, D., Tey, S., Ritchie, D. S. & Curtis, D.
31/10/18 → 30/10/23
Project: Research
-
Study of using Cyclophosphamide After Sibling-donor allogenic stem-cell Transplantation (CAST) in patients with acute leukaemia and Myelodysplasia: a randomised study comparing cyclosporin and methotrexate to cyclosporin and post-transplantation cyclophosphamide for graft-versus-host disease prophylaxis.
Curtis, D., Fleming, S. A., Patil, S. & Kennedy, N.
23/10/18 → 23/10/23
Project: Research
-
An International Phase Ib multicentre study to characterize the safety and tolerability of intravenously administered S64315, a selective Mcl-1 inhibitor, in combination with orally administered venetoclax, a selective Bcl-2 inhibitor, in patients with Acute Myeloid Leukaemia (AML).
Wei, A. & Kennedy, N.
23/10/18 → 23/10/22
Project: Research
-
A Phase 1, 2-Part, Multicenter, Open-label, 3-Arm Study to Determine the effect of Enasidenib (CC-90007) on the Pharmacokinetics of Single Doses of Caffeine, Dextromethorphan, Flurbiprofen, Midazolam, Omeprazole, Digoxin, Rosuvastatin, and Pioglitazone in Subjects with Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring an Isocitrate Dehydrogenase 2 Mutation
Wei, A. & Kennedy, N.
12/10/18 → 12/10/23
Project: Research
-
MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.
Van Der Walt, A. & Lechner-Scott, J.
5/10/18 → 30/11/22
Project: Research
-
-
MS Reactor - Prospective clinic and home-based monitoring of cognition in relapsing remitting multiple sclerosis.
4/10/18 → 30/11/22
Project: Research
-
A Phase 3, multicentre, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL 112 in subjects with Acute Coronary Syndrome protocol #: CSL 112_3001 (the ApoA-1 Event ReducinG in Ischaemic Syndromes II (AEGIS-II) Study.
1/10/18 → 1/10/24
Project: Research
-
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Locally Advanced Rectal Cancer: A Multicentre Randomised Study. (DYNAMIC-RECTAL).
Gill, S. & Cross, N.
30/09/18 → 30/10/24
Project: Research
-
An exploratory study of venetoclax in combination with bortezomib-cyclophosphamide-dexamethasone (VCD) induction therapy in newly diagnosed transplant eligible (NDTE MM) multiple myeloma with proteomic correlative studies.
Spencer, A., Kennedy, N., Mollee, P., Harrison, S. J., Quach, H. & Ho, P. J.
27/09/18 → 27/09/23
Project: Research
-
A Phase 1 Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects with Selected Relapsed or Refractory Hematological Malignancies.
Wei, A. & Kennedy, N.
27/09/18 → 27/09/23
Project: Research
-
CORE-VNS:Comprehensive Outcomes Registry in Subjects with Epilepsy Treated with Vagus Nerve Stimulation Therapy.
24/09/18 → 31/12/23
Project: Research
-
A Phase 1 Trial of CEND-1 in Combination with Nabpaclitaxel and Gemcitabine in Metastatic Exocrine Pancreatic Cancer.
Gill, S. & Cross, N.
20/09/18 → 20/09/23
Project: Research
-
Phase II trial PD-L1/PD-1 blockade Avelumab (MSB0010718C) with Chemoradiotherapy for Locally Advanced Resectable T3b-4/N1-2 Rectal Cancer.
Gill, S. & Cross, N.
20/09/18 → 20/09/23
Project: Research
-
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients with Idiopathic Pulmonary Fibrosis.
Glaspole, I. & Symons, K. M.
13/09/18 → 31/07/22
Project: Research
-
Prospective clinic and home-based serial monitoring of cognition in relapsing-remitting multiple sclerosis.
Van Der Walt, A. & Butzkueven, H.
13/09/18 → 13/11/22
Project: Research
-
ITEST: Innovative Tools to Expand Youth-Friendly HIV Self-Testing
Ong, J., Tucker, J. D. & Iwelunmor, J.
1/09/18 → 31/08/24
Project: Consultancy
-
UPPRITE Trial - Universal Posaconazole Prophylaxis versus Pre-emptive Posaconazole Therapy for Fungal Infection Management Post-lung Transplantation.
Morrissey, O. & Price, B.
27/08/18 → 31/12/21
Project: Research
-
Open Label Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 +/- ribavirin (RBV) in the treatment of Hepatitis C G1 and 4, in patients either eligible for liver transplant (HCC) or curative therapy or non-eligible for curative therapy but clinically stable disease post local resection, embolization or ablative therapy: HATCHeT Study - HepATocellular Cancer Hcv Therapy Study.
Kemp, W. & Mitchell, J.
7/08/18 → 7/08/23
Project: Research
-
Thrombin Responsive Nanoparticles for Prophylaxis and Treatment of Acute Thrombosis
Palazzolo, J. S. & Hagemeyer, C.
6/08/18 → 5/02/22
Project: Research
-
An Open-Label Study To Evaluate The Long-Term Safety Of Daily Oral BCX7353 In Subjects With Type I and II Hereditary Angioedema.
Zubrinich, C., Malinowski, L. & Thompson, K.
27/07/18 → 31/12/23
Project: Research
-
Multiplex Active Ration Test for the Detection of Early Stage Ovarian Cancer
1/07/18 → 30/06/21
Project: Research
-
CAST – A Randomised Phase 3 Trial of Cyclophosphamide after Sibling Allogeneic Haematopoietic Stem Cell Transplant
Curtis, D., Hill, G. R., Gottlieb, D., Patil, S., Ritchie, D. S., King, M. & Morrissey, O.
13/06/18 → 31/12/22
Project: Research
-
A registry-linked national platform trial to improve precision-based outcomes using novel therapies in acute myeloid leukaemia (AML)
Wei, A., Dawson, M. A., Reynolds, J., Bohlander, S. K., Ivey, A., Ekert, P. G., Marlton, P. & Blombery, P. A.
13/06/18 → 31/12/22
Project: Research